Expression of betaglycan, an inhibin coreceptor, in normal human ovaries and ovarian sex cord-stromal tumors and its regulation in cultured human granulosa-luteal cells

被引:27
|
作者
Liu, JQ
Kuulasmaa, T
Kosma, VM
Bützow, R
Vänttinen, T
Hydén-Granskog, C
Voutilainen, R
机构
[1] Univ Helsinki, Dept Pathol, Haartman Inst, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland
[3] Tampere Univ Hosp, Dept Pathol, Ctr Lab Med, FIN-33521 Tampere, Finland
[4] Univ Kuopio, FIN-70211 Kuopio, Finland
[5] Kuopio Univ Hosp, Dept Pediat, FIN-70211 Kuopio, Finland
[6] Kuopio Univ Hosp, Dept Pathol & Forens Med, FIN-70211 Kuopio, Finland
来源
关键词
D O I
10.1210/jc.2003-030704
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Activins and inhibins are often antagonistic in the regulation of ovarian function. TGFbeta type III receptor, betaglycan, has been identified as a coreceptor to enhance the binding of inhibins to activin type II receptor and thus to prevent the binding of activins to their receptor. In this study we characterized the expression and regulation pattern of betaglycan gene in normal ovaries and sex cord-stromal tumors and in cultured human granulosa-luteal cells from women undergoing in vitro fertilization. Expression of betaglycan mRNA was detected by RT-PCR or Northern blotting in normal ovarian granulosa, thecal, and stroma cells as well as in granulosa-luteal cells. Immunohistochemical analysis revealed positive staining for betaglycan in antral and preovulatory follicular granulosa and thecal cells and in corpora lutea of normal ovaries. Furthermore, betaglycan expression was detected in the vast majority of granulosa cell tumors, thecomas, and fibromas, with weaker staining in granulosa cell tumors compared with fibrothecomas. In cultured granulosa-luteal cells, FSH and LH treatment increased dose-dependently the accumulation of betaglycan mRNA, as did the protein kinase A activator dibutyryl cAMP and the protein kinase C inhibitor staurosporine. In contrast, the protein kinase C activator 12-O-tetradecanoyl phorbol 13-acetate had no significant effect on betaglycan mRNA levels. Treatment with prostaglandin E-2 and with its receptor EP2 subtype agonist butaprost increased betaglycan mRNA accumulation and progesterone secretion dose- and time-dependently. In summary, betaglycan gene is expressed in normal human ovarian steroidogenic cells and sex cord-stromal ovarian tumors. The accumulation of its mRNA in cultured granulosa-luteal cells is up-regulated by gonadotropins and prostaglandin E2, probably via the protein kinase A pathway. The specific expression and regulation pattern of betaglycan gene may be related to the functional antagonism of inhibins to activin signal transduction in human ovaries.
引用
收藏
页码:5002 / 5008
页数:7
相关论文
共 40 条
  • [31] Induction of cyclooxygenase-2 and prostaglandin F-2 alpha receptor expression by interleukin-1 beta in cultured human granulosa-luteal cells
    Narko, K
    Ritvos, O
    Ristimaki, A
    ENDOCRINOLOGY, 1997, 138 (09) : 3638 - 3644
  • [33] Gonadotrophins inhibit the expression of insulin-like growth factor binding protein-related protein-2 mRNA in cultured human granulosa-luteal cells
    Liu, JQ
    Kosma, VM
    Vänttinen, T
    Hydén-Granskog, C
    Voutilainen, R
    MOLECULAR HUMAN REPRODUCTION, 2002, 8 (02) : 136 - 141
  • [34] CD40 expression in normal human cornea and regulation of CD40 in cultured human corneal epithelial and stromal cells
    Iwata, M
    Soya, K
    Sawa, M
    Sakimoto, T
    Hwang, DG
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 (02) : 348 - 357
  • [35] Distinct regulation of gene expression by prostaglandin F2α (PGF2α) is associated with PGF2α resistance or susceptibility in human granulosa-luteal cells
    Tsai, SJ
    Wu, MH
    Chuang, PC
    Chen, HM
    MOLECULAR HUMAN REPRODUCTION, 2001, 7 (05) : 415 - 423
  • [36] Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells
    Laitinen, M
    Ristimaki, A
    Honkasalo, M
    Narko, K
    Paavonen, K
    Ritvos, O
    ENDOCRINOLOGY, 1997, 138 (11) : 4748 - 4756
  • [37] REGULATION OF SEX STEROID-RECEPTOR GENE-EXPRESSION BY PROGESTERONE AND TESTOSTERONE IN CULTURED HUMAN ENDOMETRIAL STROMAL CELLS
    IWAI, M
    KANZAKI, H
    FUJIMOTO, M
    KOJIMA, K
    HATAYAMA, H
    INOUE, T
    HIGUCHI, T
    NAKAYAMA, H
    MORI, T
    FUJITA, J
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (02): : 450 - 454
  • [38] The expression of vascular endothelial growth factor isoforms in cultured human endometrial stromal cells and its regulation by 17β-oestradiol
    Huang, JC
    Liu, DY
    Dawood, MY
    MOLECULAR HUMAN REPRODUCTION, 1998, 4 (06) : 603 - 607
  • [39] USE OF TISSUE-SPECIFIC PROMOTERS IN THE REGULATION OF AROMATASE CYTOCHROME-P450 GENE-EXPRESSION IN HUMAN TESTICULAR AND OVARIAN SEX CORD TUMORS, AS WELL AS IN NORMAL FETAL AND ADULT GONADS
    BULUN, SE
    ROSENTHAL, IM
    BRODIE, AMH
    INKSTER, SE
    ZELLER, WP
    DIGEORGE, AM
    FRASIER, SD
    KILGORE, MW
    SIMPSON, AER
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (06): : 1616 - 1621
  • [40] USE OF TISSUE-SPECIFIC PROMOTERS IN THE REGULATION OF AROMATASE CYTOCHROME-P450 GENE-EXPRESSION IN HUMAN TESTICULAR AND OVARIAN SEX CORD TUMORS, AS WELL AS IN NORMAL FETAL AND ADULT GONADS (VOL 77, PG 1616, 1993)
    BULUN, SE
    ROSENTHAL, IM
    BRODIE, AMH
    INKSTER, SE
    ZELLER, WP
    DIGEORGE, AM
    FRASIER, SD
    KILGORE, MW
    SIMPSON, ER
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (02): : 495 - +